• Explore /
  • Poster
  • / Gemcitabine plus nab-paclitaxel versus gemcitabine alone in elderly patients aged 76 years or older with unresectable pancreatic cancer: A propensity score-matched multicenter prospective observational study.

Gemcitabine plus nab-paclitaxel versus gemcitabine alone in elderly patients aged 76 years or older with unresectable pancreatic cancer: A propensity score-matched multicenter prospective observational study.

Abstract Poster

Authors

null

Satoshi Kobayashi

Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Yokohama, Japan

Satoshi Kobayashi , Motoko Suzuki , Makoto Ueno , Yuta Maruki , Junji Furuse , Akiko Todaka , Masato Ozaka , Kunihiro Tsuji , Kazuhiko Shioji , Keitaro Doi , Yasushi Kojima , Hidetaka Tsumura , Kazunari Tanaka , Hajime Higuchi , Ken Kawabe , Takeharu Yamanaka , Hiroshi Ishii

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

UMIN000034265

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4123)

DOI

10.1200/JCO.2021.39.15_suppl.4123

Abstract #

4123

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Kenji Ikezawa

First Author: Hiroyuki Asama

First Author: Atsushi Oba

First Author: Yusuke Hashimoto